Patienter bør informeres om, at de kan udvikle træthed, døsighed eller konfusion under behandling med IntronA, og derfor anbefales det, at de undgår at føre bil og betjene maskiner.
Patients are to be advised that they may develop fatigue, somnolence, or confusion during treatment with IntronA, and therefore it is recommended that they avoid driving or operating machinery.